According to researchers from the University of Pittsburgh, people who intensively control their blood glucose after being diagnosed for type 1 diabetes live longer than those who don’t.
Type 1 diabetes results when the body does not produce insulin, a hormone that is needed to convert sugar into energy. Patients can keep their blood glucose in a normal range by regularly monitoring their blood glucose and adjusting doses of insulin as required.
The Diabetes Control and Complications Trial (DCCT) and the subsequent Epidemiology of Diabetes Control and Complications (EDIC) observational study has significantly changed treatment protocols for type 1 diabetes and improved the outlook for people with the condition over the past several decades.
Millions of people with diabetes may prevent or delay fatal complications from the disease due to the findings from the landmark DCCT/EDIC study.
The findings can be read in the current issue of the Journal of the American Medical Association.